When considering the benefits of semaglutide on cardiovascular outcomes, Bryan Williams, chief scientific and medical officer for the British Heart Foundation, says: A lot has been made of the potential benefit beyond weight loss but my view is that in reality, this is all likely to be due to the reversal of the abnormal and damaging biology of obesity by reversing the weight gain. However, semaglutide is not a permanent solution here
By reducing appetite, improving insulin signaling, lowering blood sugar, and slowing stomach emptying, these medications can be powerful tools for individuals struggling with obesity or type 2 diabetes
However, advancements in capsule formulation, such as the development of liposomal glutathione, aim to improve this absorption
doi: 10.1007/s00125-005-0107-1 35 GallwitzB